Unresectable Extrahepatic Bile Duct Cancer Completed Phase 1 / 2 Trials for CPI-613 (DB12109)

IndicationStatusPhase
DBCOND0028791 (Unresectable Extrahepatic Bile Duct Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01766219CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By SurgeryTreatment